PURPOSE: To determine differences in scleral permeability, as measured by diffusion of macromolecules, by using fluorescence recovery after photobleaching (FRAP), with reference to differences by mouse strain, scleral region, and the effect of experimental glaucoma. METHODS: In three mouse strains (B6, CD1, and B6 mice with mutation in collagen 8α2 [Aca23]), we used FRAP to measure the diffusion of fluorescein isothiocyanate-dextran, molecular weight 40 kDa, into a photobleached zone of sclera. Scleral regions near the optic nerve head (peripapillary) and two successively more anterior regions were compared. Sclera from mouse eyes subjected to chronically elevated intraocular pressure after bead injection into the anterior chamber were compared to fellow eye controls. FRAP data were compared against estimated retinal ganglion cell axon loss in glaucomatous eyes. RESULTS: Diffusion rates of dextran molecules in the sclera were significantly greater in Aca23 and B6 mice than in CD1 mice in a multivariate model adjusted for region and axial length (P < 0.0001). Dextran diffusion significantly decreased in glaucomatous eyes, and the decline increased with greater axon loss (P = 0.0003, multivariable model). Peripapillary scleral permeability was higher in CD1 than B6 and Aca23 mice (P < 0.05, multivariable model, adjusted by Bonferroni). CONCLUSIONS: Measurement of the diffusion rates of dextran molecules in the sclera showed that glaucoma leads to decreased scleral permeability in all three mouse strains tested. Among mouse strains tested, those that were more susceptible to glaucomatous loss of retinal ganglion cells had a lower scleral permeability at baseline.
PURPOSE: To determine differences in scleral permeability, as measured by diffusion of macromolecules, by using fluorescence recovery after photobleaching (FRAP), with reference to differences by mouse strain, scleral region, and the effect of experimental glaucoma. METHODS: In three mouse strains (B6, CD1, and B6 mice with mutation in collagen 8α2 [Aca23]), we used FRAP to measure the diffusion of fluorescein isothiocyanate-dextran, molecular weight 40 kDa, into a photobleached zone of sclera. Scleral regions near the optic nerve head (peripapillary) and two successively more anterior regions were compared. Sclera from mouse eyes subjected to chronically elevated intraocular pressure after bead injection into the anterior chamber were compared to fellow eye controls. FRAP data were compared against estimated retinal ganglion cell axon loss in glaucomatous eyes. RESULTS: Diffusion rates of dextran molecules in the sclera were significantly greater in Aca23 and B6 mice than in CD1mice in a multivariate model adjusted for region and axial length (P < 0.0001). Dextran diffusion significantly decreased in glaucomatous eyes, and the decline increased with greater axon loss (P = 0.0003, multivariable model). Peripapillary scleral permeability was higher in CD1 than B6 and Aca23 mice (P < 0.05, multivariable model, adjusted by Bonferroni). CONCLUSIONS: Measurement of the diffusion rates of dextran molecules in the sclera showed that glaucoma leads to decreased scleral permeability in all three mouse strains tested. Among mouse strains tested, those that were more susceptible to glaucomatous loss of retinal ganglion cells had a lower scleral permeability at baseline.
Authors: Cathy Nguyen; Frances E Cone; Thao D Nguyen; Baptiste Coudrillier; Mary E Pease; Matthew R Steinhart; Ericka N Oglesby; Joan L Jefferys; Harry A Quigley Journal: Invest Ophthalmol Vis Sci Date: 2013-03-11 Impact factor: 4.799
Authors: Baptiste Coudrillier; Jacek Pijanka; Joan Jefferys; Thomas Sorensen; Harry A Quigley; Craig Boote; Thao D Nguyen Journal: J Biomech Eng Date: 2015-02-11 Impact factor: 2.097
Authors: Matthew R Steinhart; Frances E Cone; Cathy Nguyen; Thao D Nguyen; Mary E Pease; Oliver Puk; Jochen Graw; Ericka N Oglesby; Harry A Quigley Journal: Mol Vis Date: 2012-05-01 Impact factor: 2.367
Authors: Elizabeth Cone-Kimball; Cathy Nguyen; Ericka N Oglesby; Mary E Pease; Matthew R Steinhart; Harry A Quigley Journal: Mol Vis Date: 2013-09-26 Impact factor: 2.367
Authors: Arina Korneva; Elizabeth C Kimball; Joan L Jefferys; Harry A Quigley; Thao D Nguyen Journal: J R Soc Interface Date: 2020-12-16 Impact factor: 4.118
Authors: Elizabeth C Kimball; Cathy Nguyen; Matthew R Steinhart; Thao D Nguyen; Mary E Pease; Ericka N Oglesby; Brian C Oveson; Harry A Quigley Journal: Exp Eye Res Date: 2014-10-05 Impact factor: 3.467
Authors: Lixia Luo; Jin Yang; Yumin Oh; Matthew J Hartsock; Shiyu Xia; Yoo-Chun Kim; Zheng Ding; Tuo Meng; Charles G Eberhart; Laura M Ensign; Jennifer E Thorne; Walter J Stark; Elia J Duh; Qingguo Xu; Justin Hanes Journal: J Control Release Date: 2019-01-17 Impact factor: 9.776
Authors: Michaël J A Girard; William J Dupps; Mani Baskaran; Giuliano Scarcelli; Seok H Yun; Harry A Quigley; Ian A Sigal; Nicholas G Strouthidis Journal: Curr Eye Res Date: 2014-05-15 Impact factor: 2.424
Authors: Ericka N Oglesby; Gülgün Tezel; Elizabeth Cone-Kimball; Matthew R Steinhart; Joan Jefferys; Mary E Pease; Harry A Quigley Journal: Mol Vis Date: 2016-01-29 Impact factor: 2.367
Authors: Cathy Nguyen; Dan Midgett; Elizabeth C Kimball; Matthew R Steinhart; Thao D Nguyen; Mary E Pease; Ericka N Oglesby; Joan L Jefferys; Harry A Quigley Journal: Invest Ophthalmol Vis Sci Date: 2017-02-01 Impact factor: 4.799
Authors: Harry A Quigley; Ian F Pitha; Derek S Welsbie; Cathy Nguyen; Matthew R Steinhart; Thao D Nguyen; Mary Ellen Pease; Ericka N Oglesby; Cynthia A Berlinicke; Katherine L Mitchell; Jessica Kim; Joan J Jefferys; Elizabeth C Kimball Journal: PLoS One Date: 2015-10-27 Impact factor: 3.240